316
Views
0
CrossRef citations to date
0
Altmetric
Letters to the Editor

Central nervous system involvement (Bing-Neel Syndrome) in patients with Waldenström macroglobulinemia

ORCID Icon, , , ORCID Icon, , ORCID Icon, , , , , ORCID Icon & ORCID Icon show all
Pages 1490-1493 | Received 01 Dec 2022, Accepted 21 Mar 2023, Published online: 10 Jun 2023

References

  • Buske C, Leblond V. Waldenstrom’s macroglobulinemia. In: Dreyling M, Ladetto M, editors. Indolent lymphomas. New York (NY): Springer; 2021. p. 143–161.
  • Kapoor P, Ansell SM, Fonseca R, et al. Diagnosis and management of Waldenstrom macroglobulinemia: mayo stratification of macroglobulinemia and risk-adapted therapy (mSMART) guidelines 2016. JAMA Oncol. 2017;3(9):1257–1265.
  • Abeykoon JP, Zanwar S, Ansell SM, et al. Predictors of symptomatic hyperviscosity in Waldenstrom macroglobulinemia. Am J Hematol. 2018;93(11):1384–1393.
  • Castillo JJ, Gustine J, Meid K, et al. Histological transformation to diffuse large B-cell lymphoma in patients with Waldenstrom macroglobulinemia. Am J Hematol. 2016;91(10):1032–1035.
  • Zanwar S, Abeykoon JP, Ansell SM, et al. Primary systemic amyloidosis in patients with Waldenstrom macroglobulinemia. Leukemia. 2019;33(3):790–794.
  • Durot E, Kanagaratnam L, Zanwar S, et al. A prognostic index predicting survival in transformed Waldenström macroglobulinemia. Haematologica. 2021;106(11):2940–2946.
  • Zanwar S, Abeykoon JP, Durot E, et al. Impact of MYD88(L265P) mutation status on histological transformation of Waldenström macroglobulinemia. Am J Hematol. 2020;95(3):274–281.
  • Minnema MC, Kimby E, D'Sa S, et al. Guideline for the diagnosis, treatment and response criteria for Bing-Neel syndrome. Haematologica. 2017;102(1):43–51.
  • Castillo JJ, Treon SP. How we manage Bing-Neel syndrome. Br J Haematol. 2019;187(3):277–285.
  • Bing J, Neel AV. Two cases of hyperglobulinaemia with affection of the central nervous system on a toxi-infectious basis.1. Acta Medica Scandinavica. 2009;88(5–6):492–506.
  • Drozd-Sokołowska J, Waszczuk-Gajda A, Witkowska M, et al. Bing-Neel syndrome, a rare presentation of Waldenström macroglobulinemia-A multicenter report by the polish lymphoma research group. J Clin Med. 2022;11(15):4447.
  • Wong J, Cher L, Griffiths J, et al. Efficacy of zanubrutinib in the treatment of Bing-Neel syndrome. Hemasphere. 2018;2(6):e155.
  • Castillo JJ, D'Sa S, Lunn MP, et al. Central nervous system involvement by Waldenström macroglobulinaemia (Bing-Neel syndrome): a multi-institutional retrospective study. Br J Haematol. 2016;172(5):709–715.
  • Simon L, Fitsiori A, Lemal R, et al. Bing-Neel syndrome, a rare complication of Waldenström macroglobulinemia: analysis of 44 cases and review of the literature. A study on behalf of the French innovative leukemia organization (FILO). Haematologica. 2015;100(12):1587–1594.
  • Castillo JJ, Itchaki G, Paludo J, et al. Ibrutinib for the treatment of Bing-Neel syndrome: a multicenter study. Blood. 2019;133(4):299–305.
  • Saburi M, Saburi Y, Kawano K, et al. Successful treatment with tirabrutinib for relapsed lymphoplasmacytic lymphoma complicated by Bing-Neel syndrome. Int J Hematol. 2022;115(4):585–589.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.